tradingkey.logo
tradingkey.logo
검색

ReShape Lifesciences Inc

RSLS
관심 목록에 추가
3.920USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
10.29M시가총액
손실P/E TTM

ReShape Lifesciences Inc

3.920
0.0000.00%

자세한 내용은 ReShape Lifesciences Inc 회사

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

ReShape Lifesciences Inc 정보

종목 코드 RSLS
회사 이름ReShape Lifesciences Inc
상장일Oct 06, 2016
CEOMr. Paul F. Hickey
직원 수17
유형Ordinary Share
회계 연도 종료Oct 06
주소1001 Calle Amanecer
도시SAN CLEMENTE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호92673
전화19494296680
웹사이트https://www.reshapelifesciences.com/obalon/
종목 코드 RSLS
상장일Oct 06, 2016
CEOMr. Paul F. Hickey

ReShape Lifesciences Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--

자주 묻는 질문

ReShape Lifesciences Inc의 상위 5대 주주는 누구인가요?

ReShape Lifesciences Inc의 상위 5대 주주는 다음과 같습니다: Mr. Krishna Gupta

ReShape Lifesciences Inc(RSLS)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, ReShape Lifesciences Inc의 주식을 보유한 기관은 총 34곳이며, 이들이 보유한 주식의 총 가치는 약 207.69K로 전체 발행 주식의 2.96%를 차지합니다. 이는 2025Q4 대비 148618.00 증가한 수치입니다.